about
Mental health reform in the Russian Federation: an integrated approach to achieve social inclusion and recoveryEconomic downturns, universal health coverage, and cancer mortality in high-income and middle-income countries, 1990–2010: a longitudinal analysisAligning values and outcomes in priority-setting for healthEbola research funding: a systematic analysis, 1997-2015Investments in respiratory infectious disease research 1997-2010: a systematic analysis of UK fundingDifferences in research funding for women scientists: a systematic comparison of UK investments in global infectious disease research during 1997-2010Does task shifting yield cost savings and improve efficiency for health systems? A systematic review of evidence from low-income and middle-income countries.Expansion of health insurance in Moldova and associated improvements in access and reductions in direct payments.Investments in cancer research awarded to UK institutions and the global burden of cancer 2000-2013: a systematic analysis.Do changes to supply chains and procurement processes yield cost savings and improve availability of pharmaceuticals, vaccines or health products? A systematic review of evidence from low-income and middle-income countriesPrioritizing medication safety in care of people with cancer: clinicians' views on main problems and solutionsHealth impact of external funding for HIV, tuberculosis and malaria: systematic review.Funding infectious disease research: a systematic analysis of UK research investments by funders 1997-2010Investing in sepsis research: systematic analysis of UK public and philanthropic funding 1997-2010.Health systems strengthening: a common classification and framework for investment analysisImpact of Noncommunicable Disease Multimorbidity on Healthcare Utilisation and Out-Of-Pocket Expenditures in Middle-Income Countries: Cross Sectional Analysis.Investments in sexually transmitted infection research, 1997-2013: a systematic analysis of funding awarded to UK institutionsIntegration of antenatal care services with health programmes in low- and middle-income countries: systematic review.Clinician-identified problems and solutions for delayed diagnosis in primary care: a PRIORITIZE studyIdentification of priorities for improvement of medication safety in primary care: a PRIORITIZE study.Prioritizing problems in and solutions to homecare safety of people with dementia: supporting carers, streamlining care.Mapping Investments and Published Outputs in Norovirus Research: A Systematic Analysis of Research Funded in the United States and United Kingdom During 1997-2013.Health systems' responses to 25 years of HIV in Europe: inequities persist and challenges remain.Methods for estimating the burden of antimicrobial resistance: a systematic literature review protocol.Preventing delayed diagnosis of cancer: clinicians' views on main problems and solutions.Social determinants of health, universal health coverage, and sustainable development: case studies from Latin American countries.Expanding global access to radiotherapy.Health-care system frailties and public health control of communicable disease on the European Union's new eastern border.Investment in pneumonia and pneumococcal research.UK investments in global infectious disease research 1997-2010: a case study.Effect of primary health care reforms in Turkey on health service utilization and user satisfaction.Improving the doctor-manager relationship. Doctors and managers need to speak a common languageAddressing the unknowns of antimicrobial resistance: quantifying and mapping the drivers of burden.Funding healthcare-associated infection research: a systematic analysis of UK research investments, 1997-2010.The health crisis in Russia.Seasonal variation and hospital utilization for tuberculosis in Russia: hospitals as social care institutions.Shifting chronic disease management from hospitals to primary care in Estonian health system: analysis of national panel data.Mental health care reforms in Europe: Rehabilitation and social inclusion of people with mental illness in Russia.Brazil's Family Health Strategy: factors associated with programme uptake and coverage expansion over 15 years (1998-2012).Global Task Force on Radiotherapy for Cancer Control.
P50
Q24657995-5730D725-FDBE-4A74-A3C3-B0CE68020320Q28005506-1C0DD1D5-9E13-4DAB-BBCE-83E34062B163Q28066942-3B4461F6-0FA7-4FD4-92A9-FD2D93511CEAQ28119506-6A327632-1838-4930-B763-5BF5D6F4163BQ28660405-C3648253-409F-4872-A05C-660C75A972CDQ28661087-4E62058D-BFD8-4AE7-861A-0FB14D077DD3Q30377635-BF3D77CC-2CC3-4989-B4F1-58561F930334Q30380236-3810B1CA-DAF7-4687-BF0D-6A0509115A8CQ30491468-ADDB8EF5-5991-425B-8BBE-63C6987BBE41Q33699228-C8E8BEFA-2E70-4723-B59A-6E7C9A569D1BQ33810926-41530E6E-C291-4E74-AD36-12174FF84A77Q34012430-8E1710C4-C3EA-44C5-A954-CBB35B0D7151Q34097272-B9CA5EBE-463A-440F-A627-72E1BEF61838Q34392738-4B367185-C78D-4994-A94D-1D8A7A5F4250Q35056465-A214E896-BE17-4775-A9B0-9BEF9EB42746Q35685827-29AC94AD-CCB7-421C-BFCF-7F2E31C46A28Q35980127-E02F6EDD-A426-4F1D-8C86-BB2E2CCEA9B7Q36032041-29E94C9E-0BCF-464C-9186-9A743B5938C8Q36129169-54FED071-BA37-42BF-B17D-01B5252C8C10Q36194472-32C66D96-3DD7-43CB-80DC-28A31AF39CACQ36254331-604A6C8F-B23F-4625-9DEA-76F5565A424AQ36440194-A3588240-E467-489A-8C25-72E34CBFB211Q37021741-9F967B24-D93F-4A02-8DA2-5195376DCDA8Q37400757-F4335AD7-86F0-4683-9592-179CF271A6CFQ37478312-E412BC14-2C89-4249-B272-725F3EFA3EECQ38280164-72BB48CB-846A-4DD9-990E-1590DF1F7F35Q38595280-5CB6B42A-9A08-4E6A-BABF-1EB70946AD0EQ38950107-03F7649C-A4B3-48EC-88B0-2B22D36F6808Q39061601-840B825B-78D2-4EE0-89C3-10F6E05C1282Q39061606-CBA9BD66-F6DD-4E69-A140-3BA7F22B51E8Q39075559-0B0FE27C-1C12-43D8-9604-C6783E4FE27CQ41982012-730E35DC-7DE1-4B16-AE1F-FACF8B5BA3DDQ41987135-0ED2AEB3-18EF-4935-97C7-C48249842D79Q42215846-A7D34D7B-5E5E-4C57-8CFC-3EAF765BC556Q43106147-CC4E2DFB-77E2-463D-B751-C757C3C042D9Q43631113-A5039778-CE11-4FBE-A7A7-DB30981861C7Q47815439-DE7659CF-DA2E-4730-B58A-37A8E61492C2Q48225861-B8391CC8-EDA8-4849-8577-676226F14873Q48532375-B2689353-62BD-4CF8-886D-52A93C8DA6F1Q49109888-15BFEAF1-344A-418B-881F-7D00DAFCB41E
P50
description
researcher
@en
wetenschapper
@nl
name
Rifat A Atun
@en
Rifat A Atun
@nl
type
label
Rifat A Atun
@en
Rifat A Atun
@nl
prefLabel
Rifat A Atun
@en
Rifat A Atun
@nl
P106
P31
P496
0000-0002-1531-5983